HEAD-TO-HEAD COMPARISON
Compound Tirzepatide vs OzempicTirzepatide vs Semaglutide
Verdict: Compound Tirzepatide (tirzepatide) is a dual GIP / GLP-1 receptor agonist; Ozempic (semaglutide) is a GLP-1 mono-agonist. In head-to-head and indirect-comparison data, tirzepatide produces larger mean weight loss and stronger HbA1c reduction at maintenance dose. Ozempic has a longer real-world track record and broader insurance coverage in some plans.
Side-by-side comparison
| Compound Tirzepatide | Ozempic | |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Manufacturer | 503A / 503B pharmacies | Novo Nordisk |
| FDA approval | Not approved as finished product | 2017 |
| Indication | Not an FDA-approved finished product. 503A compounding is restricted now that the FDA has declared the tirzepatide shortage resolved. | Type 2 diabetes glycemic control and CV risk reduction in T2D with established CV disease |
| Starting dose | Step 1 of 6 | Step 1 of 4 |
| Maintenance target | 15 mg/week | 2 mg/week |
| Titration length | ~21 weeks | ~16 weeks |
| Mean weight loss | Same molecule as Mounjaro/Zepbound; outcomes track brand when correctly compounded | ~10 to 12% mean (secondary endpoint) |
| HbA1c reduction | Same as branded tirzepatide | 1.5 to 1.8 pp (SUSTAIN) |
| Cost (US list) | Historically $250 to $500 / mo during shortage | ~$900 / mo US list |
| Insurance | Not covered | T2D indication usually covered |
Who should pick which
- Pick Ozempic if the primary clinical goal is glycemic control in Type 2 diabetes; the FDA indication aligns and insurance coverage is more reliable.
- Consider Compound Tirzepatide only with a clinician's prescription and a verified Certificate of Analysis from the supplying pharmacy. Cost is meaningfully lower than Ozempic but supply has narrowed since FDA shortage resolution.
- Consider Compound Tirzepatide (tirzepatide) if mean weight loss in published trials is the deciding factor. Dual GIP + GLP-1 mechanism produces the largest effect size in head-to-head data.
Switching between the two
Transitioning between tirzepatide and semaglutide typically restarts titration at the new product's starting dose to manage tolerability. Some clinicians use a one-step-down approach if the prior agent was at maintenance.
Open Tirzepatide Dose Calculator → Compare full titration schedules side by sideFrequently asked
Is Compound Tirzepatide better than Ozempic?
Compound Tirzepatide (tirzepatide) is a dual GIP / GLP-1 receptor agonist; Ozempic (semaglutide) is a GLP-1 mono-agonist. In head-to-head and indirect-comparison data, tirzepatide produces larger mean weight loss and stronger HbA1c reduction at maintenance dose. Ozempic has a longer real-world track record and broader insurance coverage in some plans.
Can I switch from Compound Tirzepatide to Ozempic?
Transitioning between tirzepatide and semaglutide typically restarts titration at the new product's starting dose to manage tolerability. Some clinicians use a one-step-down approach if the prior agent was at maintenance.
Does Compound Tirzepatide produce more weight loss than Ozempic?
Compound Tirzepatide: Same molecule as Mounjaro/Zepbound; outcomes track brand when correctly compounded. Ozempic: ~10 to 12% mean (secondary endpoint). Direct comparisons depend on dose, duration, and population studied; check the linked trial citations on each brand page for full context.
Why is Compound Tirzepatide priced differently from Ozempic?
Compound Tirzepatide costs Historically $250 to $500 / mo during shortage; Ozempic costs ~$900 / mo US list. Differences reflect manufacturer pricing strategy, FDA indication (obesity-labeled brands often face patchier insurance coverage than diabetes-labeled brands), and whether the product is a finished drug or a pharmacy compound.
Which is better for Type 2 diabetes, Compound Tirzepatide or Ozempic?
Ozempic is FDA-approved for Type 2 diabetes; Compound Tirzepatide is not. For T2D-specific use, the labeled product is the appropriate clinical choice.
Related
For research informational use only. Not medical advice. Ozempic is a registered trademark of its manufacturer. Consult a qualified healthcare provider for clinical decisions.